Skip to content.

Khiron Life Sciences Corp. completes C$4.6M overnight brokered offering

Date Closed

June 10, 2022

Lead Office


On June 10, 2022, Canaccord Genuity Corp. ("Canaccord Genuity"), as lead Underwriter, closed its C$4.6 million overnight brokered offering with Khiron Life Sciences Corp. The Underwriters also included ATB Capital Markets Inc. and Leede Jones Gable Inc. A total of 30,705,000 Units were sold at a price of $0.15 per Unit for aggregate gross proceeds of C$4.6 million.

Canaccord Genuity, headquartered in Vancouver, British Columbia, is a global, full-service investment bank focused on growth companies with operations worldwide.

Khiron Life Sciences, headquartered in Toronto, Ontario, is an international medical cannabis corporation which leverages medical health clinics and proprietary  telemedicine platforms.

McCarthy Tetrault advised Canaccord Genuity with a team led by Nancy Choi that included Samantha Pettinato and Lama Kahiel (Business).